MaRS clients at the heart of health care and life sciences innovation in Ontario

 

The MaRS life sciences and health care practice works with entrepreneurs in regenerative medicine, healthy aging, improved quality and access to health care and tools for evidence-based medicine.

See how some of our life sciences and health care clients are building global businesses!



Arctic DX Inc. is the developer of two molecular diagnostic tests: Colo Risk™, for colorectal cancer, and Macula Risk™, for age-related macular degeneration.



MedCurrent has developed a simple-to-use web-based tool that guides doctors to the best radiology test to order for each specific patient. This approach is more effective, less expensive and more favorably accepted by physicians than traditional methods of ordering tests.





NeurAxon Inc. discovers and develops next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.



Profound Medical offers an MRI-guided transurethral ultrasound device for less invasive, more precise treatment of prostate cancer, allowing unparalleled treatment planning options.




Rejuven8 Laboratories Inc. is an IP-driven green life sciences company that creates and distributes earth-friendly consumer products. Its first commercial product, Weedphyter®, is the only green product that kills weeds by targeting the growth zone at root.

Tags: ,

 
 
Get More From MaRS   MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

Please enter your email address to subscribe to our newsletter